Report ID: SQMIG15E2386
Report ID:
SQMIG15E2386 |
Region:
Global |
Published Date: March, 2024
Pages:
184
|
Tables:
66 |
Figures:
75
In November 2023, ChitogenX Inc., a clinical-stage regenerative medicine company, announced that it has launched a new development program targeting significant unmet medical needs in the burn and skin repair market, currently valued at US $19B and growing at 5% + CAGR through 2032. New patent in US and Canada supports ChitogenX' proprietary chitosan-based biopolymer as ideal combination with cellular regeneration technologies.
In September 2023, Green chemistry startup Tidal Vision raised more than $20 million and announced the acquisition of one of its customers for an undisclosed sum. The Bellingham, Wash.-based business turns waste crab shells into a versatile, biodegradable polymer called chitosan (pronounced “kite-osan”) that can be used for wide-ranging industrial purposes.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG15E2386